Miltenyi Biotec
Miltenyi Biotec home - back to start page
Home ¦ Contact ¦ Ordering ¦ Terms & conditions ¦ Legal notes ¦ Jobs ¦ Forum ¦ Business development ¦ Sitemap
Miltenyi Biotec home - back to start page
Miltenyi Biotec home - back to start page
Miltenyi Biotec
MACS® Cell SeparationMiltenyi BiotecMACS® Cell AnalysisMiltenyi BiotecMACS® Cell CultureMiltenyi BiotecMACSmolecularMiltenyi BiotecClinical ProductsMiltenyi BiotecIndustrial ServicesMiltenyi BiotecMiltenyi BiotecCustomer supportMiltenyi BiotecCompany

Miltenyi Biotec
MACS® Tools for neuroscience research
Tregs—the complete portfolio
Comprehensive Genomics Services, just send your samples…
Baxter products
gentleMACS™ Dissociator
MACS Cytokines and Growth Factors
MACS eNewsletter
Subscribe to the
MACS eNewsletter
for regular product information via e-mail.
Miltenyi Biotec
CD90.2 MicroBeads
Description
The mouse CD90 (Thy1.2) antigen is expressed at high levels on retinal ganglion cells, thymocytes and peripheral T cells in lymphoid organs and blood, and at lower levels on early hematopoietic stem cells in the bone marrow, on interepithelial cells (dendritic epidermal T cells) and in skin. It does not cross-react with Thy1.1.
Applications
Mouse CD90.2 MicroBeads are suitable for positive selection of mouse retinal ganglion cells from single-cell suspensions of retinal tissue,1–5 for positive selection or depletion of T cells from single-cell suspensions of lymphoid and non-lymphoid tissues or from peripheral blood.
Columns
MS, LS, XS, or autoMACS™ Columns.
 
Miltenyi Biotec
Customer login
Customer login
Forgot your password?
New customer?
Get more information
My favorites
Your current favorite list is empty.
Products
CD90.2 MicroBeads, mouse
for 2Ă—109 total cells
Download data sheet
130-049-101
Qty:
 

Related products
Neural Tissue Dissociation Kits
gentleMACS Starting Kit (#130-093-235)
MACSmix Tube Rotator (#130-090-753)
CD90.2 antibodies
MACS References
1. Wu et al. (2003) IOVS 44 (6): 2783-2790.
2. Shoge et al. (1999) Neurosci. Letters 259: 111–114. [843]
3. Tsumamoto et al. (2002) Brain Res. 933: 118–129. [7551]
4. Mukai et al. (2002) Jpn. J. Pharmacol. 89:44–52.
5. Kerrison et al. (2005) Molec. Vision 11: 208–215.
Miltenyi Biotec
© 1999 - 2008 Miltenyi Biotec
Miltenyi Biotec